Magnetic Nanoparticles Improve Parkinson’s Movement in Mice

Magnetic nanoparticles injected into a deep brain region improved Parkinson’s-like movement problems in mice, an international research team reported this week. The technique, described in the journal Advanced Science by researchers at Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), RWTH Aachen, and the Universities of Maastricht and Leuven, stimulates the same brain target as surgically implanted electrodes — without any permanently implanted hardware.

Why it matters: deep brain stimulation, the standard surgical option for advanced Parkinson’s disease, requires a brain pacemaker implanted beneath the collarbone and electrodes threaded into the subthalamic nucleus (STN), a small structure deep in the brain that helps regulate movement.

The procedure is complex, is not always successful, and does not suit every patient, ScienceDaily reported. A magnetic approach could, in principle, reach the same circuits with a far simpler intervention — though so far only in animals.

Magnetic Particles Improve Movement in Mice with Parkinson's-Like Deficits

  • Scientists used tiny magnetic particles, placed in the brain’s movement-control region, to stimulate nerve cells from outside — no permanently implanted electrodes.
  • In mice with Parkinson’s-like movement deficits, the magnetic stimulation produced improvements roughly comparable to what a brain pacemaker would be expected to deliver.
  • This is early-stage animal research. It is not a treatment people with Parkinson’s can access today, and the researchers themselves expect several more years of development.

Why Parkinson’s Often Ends in Surgery

Parkinson’s disease develops as the brain cells that produce dopamine — a chemical messenger essential for smooth, coordinated movement — gradually break down. As dopamine levels fall, communication across the brain’s movement circuits becomes disrupted, producing tremor, stiffness, and slowed movement.

Medications can replace dopamine for a time, but for many patients deep brain stimulation eventually becomes an option. A device often called a brain pacemaker is implanted under the collarbone and connected to electrodes placed in the subthalamic nucleus, delivering electrical pulses that modify abnormal circuit activity.

Story on The Morning Science
Photo: themorning.science

“The procedure is relatively complex, however, and not always successful,” said Prof. Dr. Danijela Gregurec of the Department of Chemistry and Pharmacy at FAU. “This puts many Parkinson’s patients off, and not all patients are suitable candidates for one of these pacemakers.”

How the Magnets Switch Neurons On

The new technique exploits something nerve cells already do naturally: sense physical force. Neurons carry mechanosensors — specialized channels in their membranes that open when the membrane is mechanically deformed, letting electrically charged particles called ions flow in and change the cell’s electrical activity.

The team injected specially shaped magnetic nanoplatelets into the targeted brain area. When an external magnetic field is applied, the particles transform that field into tiny mechanical forces — Gregurec told ScienceDaily they “were developed in order to transform magnetic fields into tiny mechanical forces.”

The effect is microscopic but precise. Imagine a finger pressing against an inflated balloon, creating a small indentation: the particles gently deform the nearby nerve cell membranes, opening the pressure-sensitive channels and activating the neurons. “In contrast, we use the neurons’ natural mechanosensors to influence regions deep within the brain,” Gregurec said, describing the difference from conventional electrical stimulation.

Tiny magnets deep inside the brain could transform Parkinson’s treatment
Photo: ncijnetwork.com

What the Mouse Experiments Showed

The researchers worked with mice whose dopamine-producing nerve cells had been damaged, producing movement difficulties resembling those of Parkinson’s patients. Using stereotactic injection — a method that guides instruments to precise three-dimensional coordinates in the brain — they delivered the nanoparticles into the subthalamic nucleus, the same region targeted by conventional deep brain stimulation.

With an external magnetic field applied, the mice moved more effectively. “The effect is roughly equivalent to what we would have expected after implanting a brain pacemaker,” Gregurec said, as ScienceDaily reported.

Equally important for any future clinical use, the particles stayed in place over an observation period of several months, and the researchers found no signs of inflammation — a sign the particles were well tolerated, at least in this animal model.

From Brain Injections to a Wearable Headband

Delivering the particles still requires an injection directly into the brain, which is itself a surgical step. The team is now investigating two ways to reduce that burden.

One is designing particles that could be injected into the bloodstream and cross the blood-brain barrier — the protective boundary that normally blocks most blood-borne substances from entering brain tissue. The other is a compact wearable device, possibly a headband patients could put on themselves, to generate the magnetic field needed for stimulation.

Both ideas remain at an early stage, and the researchers expect several more years of development before the technology could be considered for clinical use. Regulatory paths are also still theoretical: any human application would need to clear approval processes such as those run by the U.S. Food and Drug Administration in the United States and the European Medicines Agency in Europe, neither of which has evaluated this technique.

“Nevertheless, we are convinced that the new method has enormous potential,” Gregurec said. “It is not only considerably simpler and cheaper than a conventional brain pacemaker, it is probably also more flexible. Adjusting the parameters of the magnetic field would allow us to control the nanoparticles more accurately.”

Feature Conventional deep brain stimulation Magnetic nanoparticle approach (experimental)
Stimulation method Electrical pulses from implanted electrodes Mechanical forces from magnetic nanoparticles
Target region Subthalamic nucleus Subthalamic nucleus
Permanent implant Yes — pacemaker and electrodes No external electrodes; particles injected in place
Evidence so far Established clinical use in patients Mouse studies only; several years from clinical consideration

What Remains Unproven

Mouse models of Parkinson’s replicate only part of the human disease, and the long-term behavior of nanoparticles in human brain tissue is unknown. The technique’s value as a research tool — letting scientists stimulate nerve cells with controlled mechanical forces — is, for now, its most immediate application.

Seek Medical Advice Before Using Unapproved Magnetic Stimulation Products

No contraindications can be established for a technique that has not been tested in humans. People with Parkinson’s disease should not seek out magnetic stimulation products marketed for neurological conditions; no such therapy is approved by the FDA, EMA, or comparable regulators.

Anyone experiencing worsening tremor, rigidity, slowed movement, or medication side effects should consult their neurologist, who can assess whether established options — medication adjustment or conventional deep brain stimulation — are appropriate for their case.

The finding, published this week in Advanced Science, shows how stimulation might occur without implanted electrodes. Whether a magnetic headband for Parkinson’s patients ever reaches a clinic will depend on trials that have not yet begun.

References

  • ScienceDaily: “Tiny magnets deep inside the brain could transform Parkinson’s treatment” (reporting on the FAU-led study, Nov. 18)
  • Advanced Science — original peer-reviewed publication by the FAU, RWTH Aachen, Maastricht, and Leuven research teams

Readers should consult a qualified healthcare professional regarding any neurological condition or treatment decision.

Photo of author

Health Desk

Health Desk at Archyde.

Nicholls Century Helps NZ Recover to 214-5 v India